Crescent Biopharma (CBIO) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.38% |
| Dec 31, 2025 | 9.24% |
| Sep 30, 2025 | -1.38% |
| Mar 31, 2025 | -32.05% |
| Dec 31, 2024 | -26.14% |
| Sep 30, 2024 | -39.03% |
| Jun 30, 2024 | -34.38% |
| Mar 31, 2024 | -30.69% |
| Dec 31, 2023 | -27.59% |
| Sep 30, 2023 | -25.81% |
| Jun 30, 2023 | -24.04% |
| Mar 31, 2023 | -23.16% |
| Dec 31, 2022 | -17.32% |
| Sep 30, 2022 | -14.49% |
| Jun 30, 2022 | -12.76% |
| Mar 31, 2022 | 17.21% |
| Dec 31, 2021 | 17.65% |
| Sep 30, 2021 | 17.62% |
| Jun 30, 2021 | 17.49% |
| Mar 31, 2021 | 27.82% |
| Dec 31, 2020 | 23.97% |
| Sep 30, 2020 | 21.59% |
| Mar 31, 2020 | 27.16% |
| Dec 31, 2019 | 23.44% |
| Sep 30, 2019 | 22.73% |
| Jun 30, 2019 | 22.70% |
| Mar 31, 2019 | 27.98% |
| Dec 31, 2018 | 146.41% |
| Sep 30, 2018 | 95.54% |
| Jun 30, 2018 | 84.34% |
| Mar 31, 2018 | 78.23% |